Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GOSERELIN for Prostate cancer: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 2,080 adverse event reports in the FDA FAERS database where GOSERELIN was used for Prostate cancer.

Most Reported Side Effects for GOSERELIN

Side Effect Reports % Deaths Hosp.
Death 1,293 20.3% 1,293 99
Malignant neoplasm progression 935 14.7% 85 114
Metastases to bone 397 6.2% 34 69
Neutropenia 339 5.3% 16 45
Fatigue 309 4.9% 27 76
Off label use 272 4.3% 22 68
Metastases to liver 264 4.1% 15 26
Hot flush 263 4.1% 23 47
Asthenia 213 3.3% 34 64
Arthralgia 190 3.0% 9 57
Drug ineffective 189 3.0% 21 55
Disease progression 181 2.8% 24 14
Nausea 177 2.8% 7 43
Pain 167 2.6% 16 50
Breast cancer 151 2.4% 10 10

Other Indications for GOSERELIN

Product used for unknown indication (1,345) Breast cancer (707) Breast cancer metastatic (396) Breast cancer female (190) Neoplasm malignant (136) Prostate cancer metastatic (136) Her2 positive breast cancer (99) Invasive ductal breast carcinoma (78) Endometriosis (76) Her2 negative breast cancer (67)

Other Drugs Used for Prostate cancer

LEUPROLIDE (45,399) ENZALUTAMIDE (25,954) RELUGOLIX (18,752) ABIRATERONE (12,209) APALUTAMIDE (3,286) DEGARELIX (2,035) BICALUTAMIDE (1,832) SIPULEUCEL-T (1,720) DENOSUMAB (1,627) DOCETAXEL (1,551)

Related Pages

GOSERELIN Full Profile All Prostate cancer Drugs GOSERELIN Demographics GOSERELIN Timeline